More Action Against Novartis As Korea FTC Issues Fine For Unfair Promotion
Executive Summary
In another blow to Novartis, South Korea's Fair Trade Commission has imposed a fine on the South Korean subsidiary of the Swiss firm for carrying out unfair promotion of its products at meetings for medical professionals.